Eloise Mastrangelo

Via Corti 12
Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Structure, substrate recognition and therapeutic targeting of the human ADAMTS-5 spacer domain.

Structure, substrate recognition and therapeutic targeting of the human ADAMTS-5 spacer domain.

Journal: Acta crystallographica. Section D, Structural biology

Published: August 26, 2025

Structural biology of ferritin nanocages.

Structural biology of ferritin nanocages.

Journal: FEBS letters

Published: July 31, 2025

Aryl Guanyl Hydrazones: A Viable Strategy for Designing BBB-Permeable, Neuroactive Compounds?

Aryl Guanyl Hydrazones: A Viable Strategy for Designing BBB-Permeable, Neuroactive Compounds?

Journal: ACS chemical neuroscience

Published: July 22, 2025

Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer.

Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer.

Journal: Scientific reports

Published: January 17, 2025

Structural snapshots of the aldol condensation reaction of the enzyme trans-o-hydroxybenzylidenepyruvate hydratase-aldolase from Pseudomonas fluorescens N3.

Structural snapshots of the aldol condensation reaction of the enzyme trans-o-hydroxybenzylidenepyruvate hydratase-aldolase from Pseudomonas fluorescens N3.

Journal: Biochemical and biophysical research communications

Published: December 12, 2024

The antipsychotic drug lurasidone inhibits coronaviruses by affecting multiple targets.

The antipsychotic drug lurasidone inhibits coronaviruses by affecting multiple targets.

Journal: Frontiers in cellular and infection microbiology

Published: August 28, 2024

4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses.

4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses.

Journal: ACS infectious diseases

Published: August 03, 2024

Acid-sensing ion channel 3 is a new potential therapeutic target for the control of glioblastoma cancer stem cells growth.

Acid-sensing ion channel 3 is a new potential therapeutic target for the control of glioblastoma cancer stem cells growth.

Journal: Scientific reports

Published: February 02, 2024

Stabilization of the retromer complex: Analysis of novel binding sites of bis-1,3-phenyl guanylhydrazone 2a to the VPS29/VPS35 interface.

Stabilization of the retromer complex: Analysis of novel binding sites of bis-1,3-phenyl guanylhydrazone 2a to the VPS29/VPS35 interface.

Journal: Computational and structural biotechnology journal

Published: November 06, 2023

CHCHD4 binding affects the active site of apoptosis inducing factor (AIF): Structural determinants for allosteric regulation.

CHCHD4 binding affects the active site of apoptosis inducing factor (AIF): Structural determinants for allosteric regulation.

Journal: Structure (London, England : 1993)

Published: October 03, 2023

Head or tail? A molecular dynamics approach to the complex structure of TNF-associated factor TRAF2.

Head or tail? A molecular dynamics approach to the complex structure of TNF-associated factor TRAF2.

Journal: Biomolecular concepts

Published: March 31, 2023

New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells.

New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells.

Journal: Molecules (Basel, Switzerland)

Published: November 30, 2022

Showing 1-12 of 56

Last Updated: 09/26/2026